|
|
||||||||
J Thorac Cardiovasc Surg 2001;122:405
© 2001 The American Association for Thoracic Surgery
Letters to the Editor |
Imperial College School of Medicine, Hammersmith Hospital, London W12 0NN, United Kingdom
To the Editor:
To better understand the hemostatic and platelet-preserving properties of aprotinin and to address the continuing controversy whether aprotinin may be prothrombotic when given to patients undergoing cardiopulmonary bypass, one must elucidate its mechanism of action on platelets in greater detail. The article by Maquelin and associates
1 provides clinical support for a subtle mechanism
This article has been cited by other articles:
![]() |
R. C. Landis Aprotinin: Antithrombotic and Vasoactive Mechanisms of Action Seminars in Cardiothoracic and Vascular Anesthesia, December 1, 2002; 6(4): 307 - 312. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |